Keryx Biopharma Uk Ltd. LONDON


Keryx Biopharma Uk started in year 2014 as Private Limited Company with registration number 08829670. The Keryx Biopharma Uk company has been functioning successfully for 10 years now and its status is active. The firm's office is based in London at Riverbank House. Postal code: EC4R 3TT.

There is a single director in the firm at the moment - John B., appointed on 5 February 2019. In addition, a secretary was appointed - Nicole H., appointed on 5 February 2019. As of 25 April 2024, there were 4 ex directors - Scott H., Brian A. and others listed below. There were no ex secretaries.

Keryx Biopharma Uk Ltd. Address / Contact

Office Address Riverbank House
Office Address2 2 Swan Lane
Town London
Post code EC4R 3TT
Country of origin United Kingdom

Company Information / Profile

Registration Number 08829670
Date of Incorporation Thu, 2nd Jan 2014
Industry Other professional, scientific and technical activities not elsewhere classified
End of financial Year 31st December
Company age 10 years old
Account next due date Mon, 30th Sep 2024 (158 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Tue, 16th Jan 2024 (2024-01-16)
Last confirmation statement dated Mon, 2nd Jan 2023

Company staff

Nicole H.

Position: Secretary

Appointed: 05 February 2019

John B.

Position: Director

Appointed: 05 February 2019

Scott H.

Position: Director

Appointed: 09 May 2018

Resigned: 05 February 2019

Brian A.

Position: Director

Appointed: 30 April 2015

Resigned: 09 May 2018

Gregory M.

Position: Director

Appointed: 30 April 2015

Resigned: 09 May 2018

Ron B.

Position: Director

Appointed: 02 January 2014

Resigned: 30 April 2015

People with significant control

The register of PSCs that own or have control over the company consists of 2 names. As we identified, there is Akebia Therapeutics, Inc. from Cambridge, United States. This PSC is classified as "a corporate", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares. Another entity in the persons with significant control register is Keryx Biopharmaceuticals, Inc. that entered Boston, United States as the official address. This PSC has a legal form of "a corporate", owns 75,01-100% shares, has 75,01-100% voting rights. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.

Akebia Therapeutics, Inc.

245 First Street, Cambridge, Massachusetts, 02142, United States

Legal authority United States
Legal form Corporate
Country registered United States
Place registered Delaware
Registration number 4308099
Notified on 12 December 2018
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Keryx Biopharmaceuticals, Inc.

One Marina Park Drive Twelfth Floor, Boston, MA 02210, United States

Legal authority United States
Legal form Corporate
Country registered United States
Place registered Delaware
Registration number 2958400
Notified on 6 April 2016
Ceased on 12 December 2018
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company filings

Filing category
Accounts Address Annual return Confirmation statement Incorporation Officers Persons with significant control
Confirmation statement with no updates 2024/01/02
filed on: 19th, January 2024
Free Download (3 pages)

Company search

Advertisements